Your Friday Trade: Tech, Pharmaceuticals & More…

Peter Costa of Empire Executions and Charles Bobrinskoy of Ariel Investments told CNBC on Friday, how investors can prepare their portfolios for the weekend.


Costa Likes:

Microsoft—“I’ve been playing with the Bing, the new search engine, and it’s not bad," Costa told CNBC. "When they sell every Windows-based computer, they’ll have it on so they’ll have a built-in market...It will be a competitor to Google and this company has a ton of cash…I still think it has a long way to go.”

Vanguard Consumer Discretionary ETF—“A lot of underlying power in the consumer that over the next 6 to 9 months, it’s going to start rolling out," he said. "People are going to start spend more… It has a broad mix of companies in it that will help benefit the ETF.”

Bobrinskoy Likes:

Johnson & Johnson—“We think earnings are going to be up…it’s just way too cheap here,” said Bobrinskoy.

IMS Health

Accenture—“We still think there’s great value. People are worried about what they do with financial companies but there’s going to be long-term IT services growth around the world and Accenture is way too cheap at less than 12 times earnings,” he said.


No immediate information was available for Bobrinskoy or Costa.